Diagnosis, Management, and Outcome of Patients with Dedifferentiated Liposarcoma Systemic Metastasis
Markus P. Ghadimi(The University of Texas MD Anderson Cancer Center), Dina Lev(Assuta Medical Center), John E. Madewell(The University of Texas MD Anderson Cancer Center), Tariq Al‐Zaid(The University of Texas MD Anderson Cancer Center), Chiara Colombo(The University of Texas MD Anderson Cancer Center), Chad J. Creighton(Baylor College of Medicine), Alexander J. Lazar(The University of Texas MD Anderson Cancer Center), Raphael E. Pollock(The University of Texas MD Anderson Cancer Center), Anna Zhang(The University of Texas MD Anderson Cancer Center), Aviad Hoffman(The University of Texas MD Anderson Cancer Center), Yiqun Zhang(Baylor College of Medicine), Tingsheng Peng(Sun Yat-sen University)
Cited by 70
Related Papers
UALCAN: A Portal for Facilitating Tumor Subgroup Gene Expression and Survival Analyses
|Neoplasia|2017|6.5k
UALCAN: An update to the integrated cancer data analysis platform
|Neoplasia|2022|2.5k
Residual breast cancers after conventional therapy display mesenchymal as well as tumor-initiating features
|Proceedings of the National Academy of Sciences|2009|1.4k
The 2019 World Health Organization classification of tumours of the breast
|Histopathology|2020|1.1k